The pathologic changes associated with the intravenous use of Sephadex.
D000818:Animals; D001996:Bronchopneumonia / Q000139:chemically induced; D003911:Dextrans / Q000008:administration & dosage / Q000633:toxicity*; D004285:Dogs; D006099:Granuloma / Q000139:chemically induced; D007269:Injections, Intra-Arterial; D007275:Injections, Intravenous; D008168:Lung / Q000187:drug effects / Q000473:pathology; D008171:Lung Diseases / Q000139:chemically induced*; D011651:Pulmonary Artery; D001261:Pulmonary Atelectasis / Q000139:chemically induced; D011652:Pulmonary Circulation / Q000187:drug effects; D011655:Pulmonary Embolism / Q000139:chemically induced; D012501:Saphenous Vein; D013667:Technetium; D013997:Time Factors
D003911:Dextrans; D013667:Technetium